Scientists from Centogene, a company focused on rare and neurodegenerative diseases, along with their collaborators at University College London and elsewhere have published a study that links the ...
When we think of movement disorders, the tremors associated with Parkinson’s disease are probably what first spring to mind. However, there are other equally debilitating and much less well-known ...
The isolation of human embryonic stem cells (hESCs) and the discovery of human induced pluripotent stem cell (hiPSC) reprogramming have sparked a renaissance in stem cell biology, in vitro disease ...
CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, Nov. 14, 2023 (GLOBE NEWSWIRE) -- Centogene N.V. (CNTG), the essential life science partner for data-driven answers in rare and neurodegenerative ...
Scientists at Brigham and Women's Hospital and Harvard Medical School have developed a targeted genetic test to improve diagnosis for X-linked dystonia-parkinsonism (XDP), a rare and disabling ...
Oct. 14 (UPI) --A new award will help early career researchers who study dystonia, the Michael J. Fox Foundation announced Tuesday. The new Bachmann-Strauss Early Career Award is a two-year, $150,000 ...
Deep brain stimulation is a surgical brain therapy used to treat symptoms of movement disorders such as dystonia, Parkinson’s disease and epilepsy. Performing over 100 DBS procedures annually, the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results